Value of serum human epidermal growth factor receptor 2 (HER2)/ neu testing for early prediction of response to HER2/neu-directed therapies is still an open one and deserves further study in large prospective trials

Suhail M. Ali, Kim Leitzel, Allan Lipton, Walter P. Carney, Wolfgang J. Köstler

Research output: Contribution to journalLetter

13 Scopus citations
Original languageEnglish (US)
Pages (from-to)e273
JournalJournal of Clinical Oncology
Volume27
Issue number36
DOIs
StatePublished - Dec 20 2009

All Science Journal Classification (ASJC) codes

  • Oncology
  • Cancer Research

Cite this